Skip to main content

Versions

FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development (R44810)

Title:
FDA Risk Evaluation and Mitigation Strategies (REMS): Description and Effect on Generic Drug Development
Report#:
R44810
Author(s):
Agata Dabrowska
Date:
March 16, 2018